Skip to main content
Premium Trial:

Request an Annual Quote

NYSE Warns Alere of Possible Delisting for Failing to File Q1 Financials

NEW YORK (GenomeWeb) – Alere said on Tuesday that it has been warned by the New York Stock Exchange that it is not in compliance with a listing requirement after it failed to file its first quarter financial results in a timely manner. 

The NYSE has given the company six months from May 18 to file its Form 10-Q for the three months ended March 31 with the US Securities and Exchange Commission. Alere said that it anticipates it will file the document in the "near future." If it does not, the NYSE may move to delist the company's shares, or it may alternatively extend the deadline an additional six months. 

Alere said earlier this month that it needed to restate its financial results for 2014 and interim periods in order to correct errors related to the accounting for income taxes for its discontinued operations. As a result, it was unable to file its Form 10-Q for the first quarter by the original deadline "without unreasonable effort and expense."

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.